Immune Checkpoint Inhibitor-Induced Reinvigoration of Tumor-Infiltrating CD8+ T Cells Is Determined by Their Differentiation Status in Glioblastoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2564
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Exhaustion-Associated Regulatory Regions in CD8+tumor-infiltrating T Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Coaching Tumor-Infiltrating CD8+ T Cells to Eat Right

Oncoscience
Cancer ResearchOncology
2018English

Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8+ T Cells

Cancer immunology research
Cancer ResearchImmunology
2017English

CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+T Cells—Response

Cancer Research
Cancer ResearchOncology
2018English

Immune Checkpoint Inhibitor-Induced Fanconi Syndrome

Cureus
2020English

Epitherapy and Immune Checkpoint Blockade: Using Epigenetic Reinvigoration of Exhausted and Dysfunctional T Cells to Reimburse Immunotherapy Response

BMC Immunology
Immunology
2020English

Spatial Distribution of FoxP3+ and CD8+ Tumour Infiltrating T Cells Reflects Their Functional Activity

Oncotarget
Oncology
2016English

Anti-Nkg2a mAb Is a Checkpoint Inhibitor That Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells

Cell
BiochemistryGeneticsMolecular Biology
2018English

Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes

Journal of Immunology
AllergyImmunology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy